E-mail: belohlavkova@fnhk.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- ABNORMALITY OF GLUCOSE AND LIPID METABOLISM DURING NILOTINIB THERAPY – RESULTS OF ENIGMA 2 STUDY
- ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS OF TRANSPORT PROTEINS SLC22A1, ABCB1 AND ABCG2 WITH RESPONSE TO IMATINIB AND IMATINIB PLASMA LEVEL IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
- Comparison of Glucose and Lipid Metabolism Abnormality during Nilotinib, Imatinib and Dasatinib Therapy – Results of Enigma 2 Study
- COMPLEX KARYOTYPE CHANGES ARE THE STRONGEST PREDICTOR OF OUTCOME OF ALLOGENEIC TRANSPLANTATION IN MYELODYSPLASTIC SYNDROME
- DEFERASIROX REPRESENTS AN EFFECTIVE ORAL IRON CHELATOR IN LOW OR INTERMEDIATE-1 RISK PATIENTS WITH MDS – A COMPARATIVE STUDY TO THE TREATMENT WITH DEFERIPRONE
- CHRONIC EOSINOPHILIC LEUKEMIA ASSOCIATED WITH T(5;16)(Q32;P13) SENSITIVE TO IMATINIB
- IS DETECTION OF CYP3A5*3 ALLELE IN CHRONIC MYELOID LEUKEMIA PATIENTS PRIOR TO TREATMENT WITH IMATINIB MESYLATE RELEVANT?
- New Mutation in ALAS2 as the Cause of X-Linked Sideroblastic Anemia Responsive to Pyridoxine: Comparison of ALAS2-Defective and DMT1-Defective BFU-E Growth
- PROGNOSTIC INFLUENCE OF ELEVATED PRETRANSPLANT SERUM FERRITIN ON THE RESULTS AFTER ALLOGENIC HEMATOPOETIC STEM CELL TRANSPLANTATION
- Successful Treatment with Imatinib Mesylate Significantly Decreases Plasma Levels of Vascular Endothelial Growth Factor (VEGF) and Soluble Endoglin (sCD105) but Not Basic Fibroblast Growth Factor (bFGF) or Angiopoietin-2 (Ang-2) in Patients with Chro
